The objective was to assess the effect of ultrasound (US)-guidance compared to the anatomical landmark (AL) approach in patients requiring femoral artery (FA) access for coronary angiography/percutaneous coronary interventions (PCI).
Since the advent of radial artery (RA) access for coronary angiography, 1 compelling evidence has demonstrated reduced bleeding and local complications compared to femoral artery (FA) access, particularly in experimented hands. [2] [3] [4] [5] [6] [7] [8] [9] RA is now recommended as the preferred approach by several societies. [10] [11] [12] [13] [14] In the growing number of dedicated radial centers, experience with FA access will inevitably plummet, 5, 15 but remain necessary when faced with a complex coronary anatomy, or as a bailout option for radial failure. It is arguable that this transition in practice might translate into higher complication rates when FA access is required. [16] [17] [18] Considering the unfavorable prognosis conferred by FA access site bleeding following percutaneous coronary intervention (PCI), 19, 20 any strategy aiming at optimizing the technique is desirable. 21 Inadvertent sheath insertion beyond the common FA (CFA) boundaries increases rates of FA access complications. 20, 22 In that regard, real-time visualization with ultrasound (US) has been proposed as a strategy to optimize the technique. 21, 23 US-guided vascular access has become a standard of practice in the intensive care and emergency room settings. The American Society of Echocardiography and the
Society of Cardiovascular Anesthesiologists recommends US to
improve first-pass success of radial artery cannulation, 23 based on a meta-analysis of four randomized control trials, 24 but no recommendation was formulated for FA access owing to scarcity of data.
Data from randomized trials focusing on US-guidance for FA cannulation are conflicting, [25] [26] [27] [28] and none of them compared US-guidance versus the commonly used anatomical landmark (AL) approach for FA access in the specific context of coronary angiography or intervention. Fluoroscopic localization of the femoral head to guide CFA puncture can be helpful but many cardiologists still use the anatomical palpation of landmarks and pulsation.
The objective of this randomized controlled trial was to assess the effect of US-guidance compared to the standard AL approach for FA access in patients undergoing coronary angiography on intraprocedural and vascular access-site complications. In addition, a study-level meta-analysis, including the results of the randomized trial, was subsequently performed.
| METHODS
A prospective, investigator-initiated, randomized controlled trial comparing the efficacy of US-guided versus the AL approach for coronary angiography with or without percutaneous intervention (PCI) was performed at the Hôpital du Sacré-Coeur de Montréal, a tertiary care institution dedicated to radial access. The study was approved by the institutional review board, and all patients provided informed consent.
| Patients and randomization
Patients aged ≥18 years undergoing elective or urgent coronary angiography via the FA were eligible. Exclusion criteria were a known bleeding diathesis, low platelet count (<50 000/mm 3 ), international normalized ratio >1.5, pregnancy, and emergent procedure (ST-elevation myocardial infarction). Patients underwent 1:1 randomization to either the US-guided approach or the AL approach. The patients and the physicians performing the procedures were not blinded to the assignment.
| Procedures
Seven experienced interventional cardiologists were involved in the study. They were all familiar with US-probe manipulation and benefited from a specific training for US-guided vascular access before participating in the trial. The needle was inserted in the identified ideal landing zone, and its tip was imaged throughout its pathway to the CFA, either using a transverse or longitudinal view. For the AL technique, the operator identified the anterior-superior iliac spine, symphysis pubis, and the femoral pulse. Needle insertion was then guided under direct palpation of the femoral pulse. Fluoroscopic guidance was only used as bailout.
FA angiograms were performed to confirm catheter location.
Antithrombotic drugs were used as required by the clinical situation, and the use of a closure device was left at the physician's discretion.
| Outcomes
The primary endpoint was a composite of immediate procedural outcomes and access-site outcomes at day one. Immediate procedural outcomes included: access failure, ≥1 puncture attempts, transfixing arterial puncture, venipuncture, and catheter insertion outside of the CFA boundaries. Except for the catheter insertion site, immediate procedural outcomes were recorded by the operator at the time of the procedure. Access failure was defined as the need to obtain arterial access from a different site from the one initially planned. Each forward needle movement was considered a puncture attempt. Table S1 ). 29 Secondary endpoints included the individual components of the primary endpoint.
| Statistical analysis
Data are presented as absolute numbers and percentages, or median (interquartile range [IQR] ). Baseline characteristics were compared using Pearson's χ-square test, or the Mann-Whitney U test for continuous variables, as appropriate. Interobserver agreement for successful cannulation of the CFA was assessed using the kappa statistic. Primary and secondary endpoints were assessed using univariate logistic regression on an intention-to-treat basis. Risk ratios with 95% confidence intervals were reported. Based on data from randomized trials available at the inception of the study, a minimal sample size of 128 patients (64 per group) was required to obtain an 80% power to detect a significant difference between groups for the primary outcome, at a two-tailed significance level of 0.05. It was expected that the primary endpoint would be observed in approximately 50% of subjects randomized to the anatomical landmark approach. Baseline characteristics associated with a P-value <0.20
were subsequently entered in a multivariate logistic regression model.
Sex, body mass index, and presence of peripheral artery disease (PAD)
were entered into the model regardless of their distribution at baseline, given their proven independent association with access-site complications. 27, 30, 31 Interaction between the technique assignment and sex, obesity (defined as a body mass index ≥30 kg/m 2 ), presence of PAD, and use of glycoprotein IIb/IIIa inhibitors was assessed for the primary composite endpoint using logistic regression. Presence of PAD was determined independently by two blinded physicians upon review of femoral angiograms (MTG and GMG), and was defined as ≥10% stenosis at the level of the CFA. In addition, to account for a possible learning curve with the US-guided technique, a pre-specified sensitivity analysis for the first half compared to the second half of the patients was performed. Through the study, statistical significance was set at an α ≤ 0. 
| Meta-analysis
A systematic review and study-level meta-analysis were subsequently performed according to the PRISMA statement, 32 and methods are available on the Supplemental Methods. Literature search strategy is provided in Supplemental Table S2 .
3 | RESULTS
| Patients
Between July 2013 and April 2016, 129 patients were randomized, including 64 in the US-guided group, and 65 in the AL group. The main indication for coronary angiography was an acute coronary syndrome (60%), and the majority of patients underwent PCI (60%). Baseline characteristics are provided in Table 1 .
| Outcomes
Immediate procedural outcomes were available for all patients, and access-site complications rate at day one were available for 126 patients (98%). The primary endpoint occurred in 30 patients (47%) in the ultrasound group, and in 39 patients (62%) in the AL group (P = 0.09).
Secondary endpoints are reported in Table 2 . One patient in the US-guided group had right common femoral access failure (2%), and access was obtained on the left side. In the US-guided group, the only bleeding event was a BARC type 2 bleeding. In the AL group, 4 bleeding events included 3 BARC type 2, and 1 BARC type 3a bleeding leading to transfusion. No BARC type 3b, 3c, or 5 bleeding occurred in either group. The median number of puncture attempts was 1 (interquartile range: 1-2) in the US-guided group, and 2 (interquartile range: 1-3) in the AL group (P = 0.04). US-guidance was not significantly associated with the primary endpoint following multivariate adjustment (Table 3) .
Femoral angiography was performed in 122 patients, among which 4 were of insufficient quality to assess the proper position of the catheter entry site. Thus, 118 (91%) femoral angiographies were available for analysis. Rates of successful CFA cannulation were high in both the US-guided and the AL groups, respectively 86% and 91%
(P = 0.38). Cannulation was performed in the superficial FA in eight patients (7%), in the profunda FA in three patients (3%), and above the inferior epigastric artery in four patients (3%). Interobserver agreement for successful CFA cannulation was good with a κ-statistic of 0.712 (95%CI: 0.524-0.900).
There was no significant interaction between US-guidance and sex (P = 0.63 for interaction), PAD (P = 0.62), obesity (P = 0.62), or use of glycoprotein IIb/IIIa inhibitors (P > 0.99) in regards to the primary endpoint. When comparing the first half of the cohort to the second half, in the US-guided group, 39% experienced the primary endpoint, compared to 47% (P for interaction = 0.32).
| Meta-analysis
The flowchart of the literature search is presented in Supplemental Figure S1 . Four studies satisfied inclusion criteria and were included in the meta-analysis, in addition to our study, for a total of 1553 patients (784 US-guided; 769 other access strategy).
25-28
Outcomes for which data was available in at least two studies were bleeding events, first-pass success, venipunctures, and common FA cannulation. Definitions of outcomes were not standardized between trials. Supplemental Table S3 
| DISCUSSION
This manuscript reports a randomized trial of FA access for coronary artery angiography with or without PCI, combined with a metaanalysis. In the randomized trial, the primary composite endpoint of immediate procedural outcomes and access-site complications at day 
| Procedural outcomes
The four previous randomized trials investigating US-guidance for FA yielded heterogeneous results, and used different primary endpoints. [25] [26] [27] [28] In FAUST, the largest study of US-guidance for vascular access, 1004 patients with palpable FA pulse were randomized to either US-guided or fluoroscopic-guided FA cannulation. 25 The primary endpoint of successful common FA cannulation occurred in 86.4% of patients in the US-guidance group, and in 83.3% of patients in the fluoroscopic guidance group (P = 0.17), which was similar to our rates (86% with US and 91% with AL approaches). This finding was consistent in their pre-specified subgroups of obese and PAD patients. In the three other previous trials, including 110, 112, and 208 patients undergoing a non-coronary radiological procedure, the rate of successful common FA cannulation was not reported. [26] [27] [28] In the study by Dudeck et al, the number of puncture attempts was not statistically different between both groups, except in the subgroups of patients with leg circumference >60 cm or weak pulses, for which US yielded improved results. 27 In opposition, the number of attempts was significantly lower in the US-guided group in our trial, in the FAUST trial, and in the trial by Gedikoglu et al.
The rates of venipunctures were higher in our trial in both groups compared to the FAUST trial, possibly reflecting a discrepancy in reporting methods. It is important to keep in mind that venipunctures, number of attempts, and successful cannulation inside the FA boundaries were only secondary endpoints in all studies, when reported, and the absence of correction for multiple comparisons recommends a cautious interpretation of these findings. In addition, the clinical significance of these endpoints is uncertain, and they do not justify by themselves a shift toward the general adoption of US-guidance.
| Access-site complications
As bleeding portends a dismal prognosis following PCI, 19, [33] [34] [35] [36] this outcome is of particular interest for patient care optimization. Post-PCI femoral access bleeding is associated with a 14-fold increase in 30-day mortality rates. 35 In experienced hands, up to 13% of femoral punctures outside of the boundaries of the common FA have been reported 22 and a high puncture is a strong risk factor for retroperitoneal hemorrhage, a rare yet potentially lethal complication. 20, 30, 37 When pooling the results of all five studies, a significant reduction of bleeding events was observed with US-guidance (RR = 0.40; 95%CI:
0.20-0.80). Since the definition of this safety endpoint varied between studies, interpretation of these results warrant carefulness. In the FAUST trial, the rate of hematoma ≥5 cm was lower with US compared to fluoroscopic guidance (0.6% vs 2.2%, P = 0.034), but rates of access site bleeding requiring transfusions were minimal in both groups. 25 
| Limitations and strengths
Our study has some limitations. First, it reflects the practice of a center dedicated to RA access, where FA access is often reserved to more urgent indications, RA access failure, or for patients undergoing complex PCI. It does not reflect the all-comers population of centers using FA access as the default approach. Second, given the relatively small-scale of the trial, surrogate endpoints for important patientoriented outcomes were selected in the composite primary endpoint, similarly to the previous trials performed on the topic. [25] [26] [27] [28] They might not reflect clinically meaningful endpoints such as mortality or lifethreatening bleeding, which are relatively rare events in the current era in interventional cardiology. A much larger sample size would be necessary to show significant differences in clinically significant isolated endpoints. However, given the non-invasive nature of US-guidance, it is arguable that its use could be justified to improve only soft clinical endpoints. Third, a numerical trend was observed in favor of the US-guided technique for the primary composite endpoint, and it is possible that our study was underpowered. Acknowledging that our study is only the third largest among the five randomized trials published on the topic, enrollment achieved the expected sample size.
However, the event rate was higher than expected in both groups, thus the relative difference between them was overestimated at inception for sample size calculation, which might account for the statistically negative result. Fourth, due to practical constraints, operators and patients were not blinded to the treatment allocation. However, adjudication of vascular complications at day one and confirmation of puncture site on femoral angiography was performed by physicians blinded to the treatment assignment. reported rate might be underestimated. When a systematic doppler examination of the groin is performed following coronary angiography, pseudoaneurysms and AV fistulae are incidentally found in 3.7% and 0.25% of patients, respectively. 38 However, the same adjudication strategy was used in previous studies, 25, 26 and the clinical significance of identifying subclinical pseudoaneurysms and AV fistulae is doubtful.
Finally, the interventional cardiologists in our study are all experienced operators in femoral artery access, and our findings cannot translate to other settings than in the catheterization laboratory. It is possible that the magnitude of the potential benefits of US-guidance would be greater in settings where operators have less experience for FA access, such as in the intensive care unit or the emergency department.
As a strength, as opposed to three previous studies (excluding the FAUST trial), [26] [27] [28] our study involved interventional cardiologists, thus reflecting more accurately the experience and skillset of the population to which we aim to extrapolate our data. In addition, FA access for coronary angiography is usually performed under antiplatelet therapy and anticoagulation, in opposition to FA access in other settings, increasing hazards of bleeding complications. Other strengths of our trial include its randomized design, and a nearly complete followup rate. Finally, operators were only experienced interventional cardiologists, in contrast to other studies, in which fellows were allowed multiple attempts before the attending physician took over. 25 
| CONCLUSION
In conclusion, in a dedicated RA access center, the use of US-guidance for FA access for coronary angiography with or without PCI is not associated with a lower rate of the composite of immediate procedural outcomes and access-site outcomes at day one. However, the number of venipunctures and the number of puncture attempts were significantly lower. In a meta-analysis of five randomized trials, it was shown that bleeding events, and venipunctures were significantly lower with US-guidance and first-pass success was improved. The clinical impact of these findings is uncertain, and they do not warrant a FIGURE 1 Forest plots for A, bleeding events; B, more than one puncture attempt; C, venipunctures; D, catheter insertion outside of the common femoral artery boundaries systematic use of US-guidance in this specific clinical setting.
Notwithstanding the results of this study, FA access should always be performed using available state-of-the-art strategies in the quest to optimize patient care when necessary.
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